Phase III Trial of Enzalutamide (Nsc # 766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer

BH-14-099
Cancer - Prostate, Cancer
Leslie Howard, MD

D’Amour Center for Cancer Care

3350 Main Street

Springfield MA 01199


Franklin Medical Center

164 High Street

Greenfield, MA


The purpose of this study is to compare the effects, good and/or bad, of abiraterone, prednisone, and enzalutamide with enzalutamide alone on you and your prostate cancer to find out which is better.
Participants must have progressive castration-resistant metastatic prostate cancer, and rising PSA levels.
Betsy Lopez
413-794-4154